❉ Buffybot wonderful businesses, fair prices

← back

HCA HCA Healthcare

healthcare · 2026-09-16

N/A
too hard · 83
Owner-earnings value$498.12
Price$423.82
Margin of safety +17.5%

Quality gate · 83/100

Returns on capital 27.6/30
Consistency 21.2/22
Margins / pricing power 12.0/16
Balance sheet 6.4/16
Cash conversion 9.7/10
Capital allocation 6/6

⚠ negative book equity

Median ROIC21.9%
Gross margin42.6%
Net debt / EBITDA3.0x
FCF conversion95%
Share count / yr-6.8%
Profitable years4/4

Moat & management

Owner-earnings inputs

Owner earnings (TTM)6.00B
Owner-earnings yield6.4%
Free-cash-flow yield6.4%
Growth used (normalized)7.9%
Market-implied growth (reverse DCF)3.9%
Terminal growth3.0%
Discount rate (hurdle)10.0%

Projected owner earnings

YrOwner earningsGrowthPV
16.47B 7.9%5.88B
26.94B 7.3%5.74B
37.41B 6.8%5.57B
47.88B 6.2%5.38B
58.33B 5.7%5.17B
68.76B 5.2%4.95B
79.16B 4.6%4.71B
89.54B 4.1%4.45B
99.87B 3.5%4.19B
1010.17B 3.0%3.93B

Recent news

score · 8 articles

  • CVS Still Sees 'High-Trend' Cost Growth; Oscar, UNH Stock Fall
  • HCA Healthcare Delivers Consistent Message Around H2 Cadence Expectations, RBC Says
  • The Bull Case For HCA Healthcare (HCA) Could Change Following 2026 Guidance Cut And Payer Mix Strain
  • HCA Healthcare (HCA) Faces Securities Fraud Investigation With Shareholder Risks In Focus
  • HCA Healthcare (HCA) Could Be 11% Below Fair Value As Guidance Gets Cut
  • Charles River (CRL) Up 10.5% Since Last Earnings Report: Can It Continue?
  • Is HCA Healthcare Stock Underperforming the Nasdaq?
  • HCA Healthcare (HCA) Navigates Patient Volume Challenges While Reporting Growth

⚠ maintenance capex ≈ min(capex, D&A), capped at FCF · Price pays for ~4%/yr owner-earnings growth over 10y (reverse DCF); model credits 8%.

History

DateQualityPriceValueMoSRating
2026-09-16 83 $423.82 $498.12 +17.5% N/A
2026-07-28 83 $389.62 $500.18 +28.4% N/A
2026-07-02 83 $393.24 $505.34 +28.5% N/A
2026-06-25 83 $387.76 $498.78 +28.6% N/A
2026-06-23 83 $386.92 $584.29 +51.0% N/A